Daylight Photodynamic Therapy for Actinic Keratoses

Area of Science:

• Dermatology
• Photomedicine
• Oncology

Background:

• Actinic keratoses (AKs) are common precancerous skin lesions.
• Conventional photodynamic therapy (PDT) is effective but can be painful.
• Daylight-mediated PDT (DL-PDT) offers a potentially less uncomfortable alternative.

Purpose of the Study:

• To evaluate the efficacy and patient experience of DL-PDT for AK treatment.
• To compare DL-PDT with conventional PDT.
• To explore the potential of DL-PDT in preventing skin cancer development.

Main Methods:

• Application of photosensitizing agents (MAL or ALA nanoemulsion) without occlusion.
• Exposure to ambient daylight for 1.5-2.0 hours within 30 minutes of application.
• Randomized controlled trials comparing DL-PDT with conventional PDT.

Main Results:

• DL-PDT demonstrates similar efficacy to conventional PDT for thin and moderate AKs.
• DL-PDT is associated with significantly less pain and discomfort, leading to patient preference.
• Initial clearance rates range from 70-89% for MAL DL-PDT.
• ALA DL-PDT shows comparable effectiveness to MAL DL-PDT.

Conclusions:

• DL-PDT is an effective and well-tolerated treatment for extensive AK disease.
• DL-PDT offers a patient-preferred alternative to conventional PDT.
• Emerging evidence suggests DL-PDT may help prevent new AKs and potentially skin cancer.
• Further research is needed to establish DL-PDT for conditions beyond AKs.